DR Horton Ownership

DHI Stock  USD 127.06  0.28  0.22%   
DR Horton secures a total of 320.83 Million outstanding shares. The majority of DR Horton outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to obtain positions in DR Horton to benefit from reduced commissions. Hence, outside corporations are subject to a different set of regulations than regular investors in DR Horton. Please pay attention to any change in the institutional holdings of DR Horton as this could imply that something significant has changed or is about to change at the company. Please note that on March 7, 2025, Representative Josh Gottheimer of US Congress acquired under $15k worth of DR Horton's common stock.
 
Shares in Circulation  
First Issued
2009-03-31
Previous Quarter
332 M
Current Value
323 M
Avarage Shares Outstanding
355.6 M
Quarterly Volatility
22.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as DR Horton in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of DR Horton, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.

DHI Stock Ownership Analysis

About 85.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.6. Some equities with similar Price to Book (P/B) outperform the market in the long run. DR Horton has Price/Earnings To Growth (PEG) ratio of 0.5. The entity recorded earning per share (EPS) of 14.14. The firm last dividend was issued on the 7th of February 2025. DR Horton had 4:3 split on the 17th of March 2005. Horton, Inc. operates as a homebuilding company in East, North, Southeast, South Central, Southwest, and Northwest regions in the United States. Horton, Inc. was founded in 1978 and is headquartered in Arlington, Texas. DR Horton operates under Residential Construction classification in the United States and is traded on New York Stock Exchange. It employs 13237 people. To learn more about DR Horton call David Auld at 817 390 8200 or check out https://www.drhorton.com.
Besides selling stocks to institutional investors, DR Horton also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different DR Horton's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align DR Horton's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

DR Horton Quarterly Liabilities And Stockholders Equity

35.03 Billion

DR Horton Insider Trades History

About 11.0% of DR Horton are currently held by insiders. Unlike DR Horton's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against DR Horton's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of DR Horton's insider trades
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid

DHI Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as DR Horton is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading DR Horton backward and forwards among themselves. DR Horton's institutional investor refers to the entity that pools money to purchase DR Horton's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Dz Bank Ag Deutsche Zentral-genossenschaftsbank Frankfurt Am Main2024-12-31
3.8 M
Greenhaven Associates Inc2024-12-31
3.7 M
Morgan Stanley - Brokerage Accounts2024-12-31
3.6 M
Franklin Resources Inc2024-12-31
3.6 M
Dimensional Fund Advisors, Inc.2024-12-31
3.5 M
Northern Trust Corp2024-12-31
3.4 M
Ubs Asset Mgmt Americas Inc2024-12-31
2.7 M
Smead Capital Management Inc2024-12-31
2.5 M
First Trust Advisors L.p.2024-12-31
2.1 M
Vanguard Group Inc2024-12-31
33 M
Blackrock Inc2024-12-31
32 M
Note, although DR Horton's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

DR Horton Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific DR Horton insiders, such as employees or executives, is commonly permitted as long as it does not rely on DR Horton's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases DR Horton insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

DR Horton's latest congressional trading

Congressional trading in companies like DR Horton, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in DR Horton by those in governmental positions are based on the same information available to the general public.
2025-03-07Representative Josh GottheimerAcquired Under $15KVerify
2025-02-11Representative Josh GottheimerAcquired Under $15KVerify
2025-01-15Representative Josh GottheimerAcquired Under $15KVerify
2024-12-06Representative Josh GottheimerAcquired Under $15KVerify
2024-12-05Representative Josh GottheimerAcquired Under $15KVerify
2024-08-15Representative Josh GottheimerAcquired Under $15KVerify

DR Horton Outstanding Bonds

DR Horton issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. DR Horton uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most DHI bonds can be classified according to their maturity, which is the date when DR Horton has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

DR Horton Corporate Filings

F4
13th of March 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
26th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
21st of February 2025
Prospectus used primarily for registering securities for public sale.
ViewVerify
FWP
20th of February 2025
A written communication used by offering participants to offer securities to the public or to solicit securities transactions.
ViewVerify

Currently Active Assets on Macroaxis

When determining whether DR Horton offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DR Horton's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Horton Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Horton Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DR Horton. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
For more detail on how to invest in DHI Stock please use our How to Invest in DR Horton guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Household Durables space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DR Horton. If investors know DHI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DR Horton listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.07)
Dividend Share
1.3
Earnings Share
14.14
Revenue Per Share
112.352
Quarterly Revenue Growth
(0.01)
The market value of DR Horton is measured differently than its book value, which is the value of DHI that is recorded on the company's balance sheet. Investors also form their own opinion of DR Horton's value that differs from its market value or its book value, called intrinsic value, which is DR Horton's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DR Horton's market value can be influenced by many factors that don't directly affect DR Horton's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DR Horton's value and its price as these two are different measures arrived at by different means. Investors typically determine if DR Horton is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DR Horton's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.